XBI And IBB: Most 'Feared' Nation Policy, Less-Than-Feared Damage, Buy The Discount
· seekingalpha.com
Initiating Buy ratings on SPDR S&P Biotech ETF and iShares Biotechnology ETF for 2026–2027, favoring XBI over IBB for higher upside. Click to read more.
Lifescience investor focused on non-consensus long-short investment ideas. I focus on small to mid-cap biotechnology companies that are public on the US and EU ...